Liver Stiffness predicts Early Virological Response (EVR) in HIV/HCV co-infected patients treated with Pegylated interferon alpha2a (PegIFN alpha 2a) plus Ribavirin (RBV)

被引：0
|
作者：
Nasta, P. [1 ]
Gatti, F. [1 ]
Borghi, F. [1 ]
Bianchi, E. [1 ]
Mendeni, M. [1 ]
Prestini, K. [1 ]
Carosi, G. [1 ]
机构：
[1] Univ Brescia, Ist Malattie Infett & Tropicali, I-25121 Brescia, Italy
来源：
INFECTION | 2010年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [41] Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients
    Macias, Juan
    Rivero, Antonio
    Cifuentes, Celia
    Camacho, Angela
    Neukam, Karin
    Rivero-Juarez, Antonio
    Mira, Jose A.
    Torre-Cisneros, Julian
    Gomez-Mateos, Jesus
    Pineda, Juan A.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (07): : 424 - 429
  • [42] Impact of Baseline Variables on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With HIV/HCV Genotype-1
    Tural, Cristina
    Rockstroh, Juergen K.
    Nelson, Mark
    Bhagani, Sanjay
    Ingiliz, Patrick
    Soriano, Vicente
    Nunez, Marina
    Valantin, Marc-Antoine
    Madruga, Jose Valdez R.
    Rauch, Andri
    Furtado, Juvencio
    Battegay, Manuel
    Stern, Jerry O.
    Quinson, Anne-Marie
    Boecher, Wulf
    Vinisko, Richard
    Manero, Montserrat
    Dieterich, Douglas T.
    GASTROENTEROLOGY, 2014, 146 (05) : S976 - S976
  • [43] Sustained virological response of pegylated interferon α-2A plus ribavirin in patients with chronic hepatitis C genotype 4
    Shiha, G
    Gabre, M
    Zalata, K
    Sayed, S
    GUT, 2004, 53 : A81 - A81
  • [44] Influence of Hispanic ethnicity on liver histology and treatment response in HIV/HCV genotype 1 co-infected subjects on pegylated interferon and ribavirin
    Uriel, AJ
    Park, J
    Moorehead, L
    Camera, D
    Lucas, J
    Sulkowski, M
    Dieterich, DT
    GASTROENTEROLOGY, 2005, 128 (04) : A724 - A724
  • [45] Results of a study prolonging treatment with pegylated interferon-α2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response (vol 11, pg 473, 2006)
    Fuster, Daniel
    Planas, Ramon
    Gonzalez, Juan
    ANTIVIRAL THERAPY, 2006, 11 (05) : 667 - 667
  • [46] HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and Ribavirin
    Hakim, Wyel
    Sheikh, Shehzad
    Inayat, Irteza
    Caldwell, Cary
    Smith, Douglas
    Lorber, Marc
    Friedman, Amy
    Jain, Dhanpat
    Bia, Margaret
    Formica, Richard
    Mehal, Wajahat
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (05) : 477 - 481
  • [47] The safety and efficacy of Viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naive patients infected with HCV:: Phase 3 results
    Benhamou, Y.
    Pockros, P.
    Rodriguez-Torres, M.
    Gordon, S.
    Shiffman, M.
    Lurie, Y.
    Afdhal, N.
    Lamon, K.
    Kim, Y.
    Murphy, B.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S273 - S273
  • [48] Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
    Callens, S
    Bottieau, E
    Michielsen, P
    Colebunders, R
    AIDS, 2004, 18 (01) : 131 - 131
  • [49] The safety and efficacy of Viramidine® plus pegylated interferon alpha-2b versus ribavirin plus pegylated interferon alpha-2b in therapy-naive patients infected with HCV:: Phase 3 results
    Murphy, B.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S19 - S19
  • [50] Early HCV-RNA clearance in HIV/HCV-coinfected patients treated with pegylated interferon alfa-2a plus ribavirin
    Camino, N
    Nuñez, M
    Romero, M
    Barreiro, P
    Ocampo, A
    Miralles, C
    Martín-Carbonero, L
    Fernández, A
    García-Samaniego, J
    Soriano, V
    HEPATOLOGY, 2004, 40 (04) : 402A - 403A
12345